Leveraging health social networking communities in translational research

Health social networking communities are emerging resources for translational research. We have designed and implemented a framework called HyGen, which combines Semantic Web technologies, graph algorithms and user profiling to discover and prioritize novel associations across disciplines. This manuscript focuses on the key strategies developed to overcome the challenges in handling patient-generated content in Health social networking communities. Heuristic and quantitative evaluations were carried out in colorectal cancer. The results demonstrate the potential of our approach to bridge silos and to identify hidden links among clinical observations, drugs, genes and diseases. In Amyotrophic Lateral Sclerosis case studies, HyGen has identified 15 of the 20 published disease genes. Additionally, HyGen has highlighted new candidates for future investigations, as well as a scientifically meaningful connection between riluzole and alcohol abuse.

[1]  Mathew J. Palakal,et al.  A Hybrid Method to Discover and Rank Cross-Disciplinary Associations , 2009, 2009 IEEE International Conference on Bioinformatics and Biomedicine.

[2]  J. Haines,et al.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.

[3]  A. Ludolph,et al.  Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS , 2004, Neurology.

[4]  Pall I. Olason,et al.  A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.

[5]  D. Vitkup,et al.  Network properties of genes harboring inherited disease mutations , 2008, Proceedings of the National Academy of Sciences.

[6]  H. Manji,et al.  Riluzole in psychiatry: a systematic review of the literature , 2008, Expert opinion on drug metabolism & toxicology.

[7]  S. Duthie,et al.  Folic acid deficiency and cancer: mechanisms of DNA instability. , 1999, British medical bulletin.

[8]  C. Andres,et al.  Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis , 2002, Annals of neurology.

[9]  Giovanni Scardoni,et al.  Analyzing biological network parameters with CentiScaPe , 2009, Bioinform..

[10]  Claire L. Simpson,et al.  Amyotrophic lateral sclerosis as a complex genetic disease. , 2006, Biochimica et biophysica acta.

[11]  Eric K. Neumann,et al.  Identifying disease-causal genes using Semantic Web-based representation of integrated genomic and phenomic knowledge , 2008, J. Biomed. Informatics.

[12]  M. Thompson,et al.  Vitamin B12 and the Risk of Neural Tube Defects in a Folic-Acid-Fortified Population , 2007, Epidemiology.

[13]  Harith Alani,et al.  Ontology ranking based on the analysis of concept structures , 2005, K-CAP '05.

[14]  J L Haines,et al.  Supporting Online Material Materials and Methods Figs. S1 to S7 Tables S1 to S4 References Mutations in the Fus/tls Gene on Chromosome 16 Cause Familial Amyotrophic Lateral Sclerosis , 2022 .

[15]  Padhraic Smyth,et al.  Algorithms for estimating relative importance in networks , 2003, KDD '03.

[16]  R. Ophoff,et al.  ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study , 2007, The Lancet Neurology.

[17]  Fidel Ramírez,et al.  Computing topological parameters of biological networks , 2008, Bioinform..

[18]  Yongjin Li,et al.  Discovering disease-genes by topological features in human protein-protein interaction network , 2006, Bioinform..

[19]  M. Strong.  The evidence for altered RNA metabolism in amyotrophic lateral sclerosis (ALS) , 2010, Journal of the Neurological Sciences.

[20]  C. Hodge,et al.  Preclinical evaluation of riluzole: assessments of ethanol self-administration and ethanol withdrawal symptoms. , 2009, Alcoholism, clinical and experimental research.

[21]  M. Brito,et al.  Risk of colorectal cancer associated with the C677T polymorphism in 5,10-methylenetetrahydrofolate reductase in Portuguese patients depends on the intake of methyl-donor nutrients. , 2008, The American journal of clinical nutrition.

[22]  T. Gilliam,et al.  Genetic-linkage mapping of complex hereditary disorders to a whole-genome molecular-interaction network. , 2008, Genome research.

[23]  A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2 , 2001, Nature Genetics.

[24]  Yun Peng,et al.  Finding and Ranking Knowledge on the Semantic Web , 2005, SEMWEB.

[25]  F. Baas,et al.  Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS , 2001, Neurology.

[26]  Alan R. Aronson,et al.  Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program , 2001, AMIA.

[27]  O. Hardiman,et al.  Association of the H63D polymorphism in the hemochromatosis gene with sporadic ALS , 2005, Neurology.

[28]  Olivier Bodenreider,et al.  The Unified Medical Language System (UMLS): integrating biomedical terminology , 2004, Nucleic Acids Res..

[29]  M. Vidal,et al.  Networking metabolites and diseases , 2008, Proceedings of the National Academy of Sciences.

[30]  A. Hopkins.  Network pharmacology: the next paradigm in drug discovery. , 2008, Nature chemical biology.

[31]  A. Hopkins.  Network pharmacology , 2007, Nature Biotechnology.

[32]  T. Crawford,et al.  The relationship of SMN to amyotrophic lateral sclerosis , 2002, Annals of neurology.

[33]  Sonja W. Scholz,et al.  Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data , 2007, The Lancet Neurology.

[34]  Orla Hardiman,et al.  A genome-wide association study of sporadic ALS in a homogenous Irish population. , 2007, Human molecular genetics.

[35]  Sougata Mukherjea,et al.  Utilizing Resource Importance for Ranking Semantic Web Query Results , 2004, SWDB.

[36]  Jing Chen,et al.  Disease candidate gene identification and prioritization using protein interaction networks , 2009, BMC Bioinformatics.

[37]  M. Swan.  Emerging Patient-Driven Health Care Models: An Examination of Health Social Networks, Consumer Personalized Medicine and Quantified Self-Tracking , 2009, International journal of environmental research and public health.

[38]  R. Pitkin,et al.  Folate and neural tube defects. , 2007, The American journal of clinical nutrition.

[39]  Krin A. Kay,et al.  The implications of human metabolic network topology for disease comorbidity , 2008, Proceedings of the National Academy of Sciences.

[40]  Pedro Domingos.  KDD-2003 : proceedings of the Ninth ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, August 24-27, 2003, Washington, DC, USA , 2003 .

[41]  Frank Baas,et al.  Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis , 2008, Nature Genetics.

[42]  V. Drory,et al.  Association of APOE ε4 allele with survival in amyotrophic lateral sclerosis , 2001, Journal of the Neurological Sciences.

[43]  Yuval Shahar,et al.  Application of Information Technology: A Comparative Evaluation of Full-text, Concept-based, and Context-sensitive Search , 2007, J. Am. Medical Informatics Assoc..

[44]  Malorye Allison,et al.  Can web 2.0 reboot clinical trials? , 2009, Nature Biotechnology.

[45]  A. Hendricson,et al.  Aberrant Synaptic Activation of N-Methyl-d-aspartate Receptors Underlies Ethanol Withdrawal Hyperexcitability , 2007, Journal of Pharmacology and Experimental Therapeutics.

[46]  Sherry L. Jenkins,et al.  Network analysis of FDA approved drugs and their targets. , 2007, The Mount Sinai journal of medicine, New York.

[47]  Martijn J. Schuemie,et al.  A dictionary to identify small molecules and drugs in free text , 2009, Bioinform..

[48]  Catherine Arnott-Smith,et al.  PatientsLikeMe: Consumer Health Vocabulary as a Folksonomy , 2008, AMIA.

[49]  Huajun Chen,et al.  Semantic web for integrated network analysis in biomedicine , 2009, Briefings Bioinform..

[50]  A. Barabasi,et al.  Drug—target network , 2007, Nature Biotechnology.

[51]  P. Carmeliet,et al.  VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death , 2003, Nature Genetics.